PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Orlando Plastic Surgeon Combines Multiple Techniques to Achieve a Fully Rejuvenated Look and Reduce Recovery Time

Category : Stocks, World News

Dr. Jon Paul Trevisani Frequently Combines Surgical Procedures in Custom-Designed Treatment Plans That Can Reduce Overall Recovery Time and Save Patients Money

Read this article: Orlando Plastic Surgeon Combines Multiple Techniques to Achieve a Fully Rejuvenated Look and Reduce Recovery Time

Post to Twitter

SoundCure(R) Launches the Serenade(R) Tinnitus Treatment System in the UK

Category : World News

Customized Sound Therapy Approach for Ringing Ears, With Novel Treatment Sounds

Visit link: SoundCure(R) Launches the Serenade(R) Tinnitus Treatment System in the UK

Post to Twitter

Flu treatment boosts sales at Roche

Category : Business

Swiss drugmaker Roche reports a 5% rise in first quarter sales, helped by strong demand for its flu treatment, Tamiflu.

Here is the original post: Flu treatment boosts sales at Roche

Post to Twitter

TNI BioTech, Inc. (TNIB: OTC Pink Current) | TNI BioTech, Inc. Completes Financial Audit

Category : Stocks, World News

TNI BioTech, Inc. Completes Financial Audit

Post to Twitter

Beauty therapists to be banned from offering fillers unless qualified

Category : Business

Clampdown follows a review by NHS chief Sir Bruce Keogh which found the sector is full of cowboy practices

Beauty therapists are to be banned from offering injectable dermal fillers to smooth out wrinkles and rejuvenate faces unless they have been properly trained and hold a formal qualification, as part of a major review into cosmetic surgery.

The clampdown is a first shot across the bows of the industry, which an independent review led by NHS medical director Sir Bruce Keogh has found is inadequately regulated and full of cowboy practices.

Although facelifts, breast implants and other forms of surgery catch the headlines, 90% of the £2.3bn business comprises smaller, cheaper procedures such as dermal fillers, which are substances injected under the skin to plump out lines, and laser treatments for hair loss and wrinkles.

There are few controls over who can carry out these procedures. Yet Keogh’s review heard that some clients had suffered real harm when things went wrong. The injection of dermal fillers under the skin, for instance, can lead to bruising and swelling.

There have also been reports of skin necrosis – the death of skin tissue because of the blockage of blood vessels – and even of blindness.

“All too often we hear of cases that shine a light on poor practices in the cosmetic surgery industry,” said Keogh. “I am concerned that some practitioners who are giving non-surgical treatments may not have had any appropriate training whatsoever. This leaves people exposed to unreasonable risks, and possibly permanent damage.

“Our research has shown that the public expect procedures that are so widely available to be safe, whereas they are largely unregulated.

“There is a clear need for better quality, recognised training for the people performing these operations. My review will make a number of recommendations for making sure people who choose to undergo these procedures are in safe hands.”

The review will recommend that anybody offering non-surgical cosmetic interventions must either be properly trained and qualified to perform and supervise them or else qualified to carry them out under the supervision of a clinically trained superior. What those qualifications will be and who will be able to train for them has not been decided.

The British Association of Aesthetic Plastic Surgeons (BAAPS) gave the news a cautious welcome, saying it would like to see all such treatments restricted to medical professionals. “Non-surgical does not mean non-medical,” said consultant plastic surgeon and BAAPS president Rajiv Grover. “Treatment with dermal fillers has clear benefits but also risks – it is not just about who can wield a syringe but who will have the capabilities to deal with any possible complications.

“We agree that specialised training is required and [it should be] certainly more extensive than the many widely-promoted weekend courses currently available, but aesthetic injectables should only ever be provided by medical professionals.

“It is known that dermal fillers have a physiological (‘biological’) effect on skin — such as stimulating the production of collagen, and many of them also contain local anaesthetic. These factors make these substances, in essence, a medicine.”

BAAPS says many of its member surgeons have had to sort out the consequences of botched filler treatments. A recent survey found that 69% of surgeons saw patients suffering complications even from temporary fillers, while 49% saw problems with semi- or permanent fillers. Out of those patients who suffered problems with permanent substances, 84% required corrective surgery or were deemed untreatable due to the damage caused.

Keogh’s review looked at all aspects of the cosmetic surgery industry following the PIP breast implant disaster, which led to massive anxiety and thousands of women having implants removed, often on the NHS. Its full report is expected at the end of April.

“I await Sir Bruce Keogh’s recommendations in full, but am clear that we must ensure that people undergoing cosmetic procedures are in the hands of someone with the right skills and training,” said health minister Dan Poulter. “The days of cosmetic cowboys must become a thing of the past.”

Viratech Corp. (VIRA: OTC Link) | Viratech Announces agreement For Marketing License of Device Used For Breast Health

Category : Stocks

VIRATECH ANNOUNCES AGREEMENT FOR MARKETING LICENSE OF DEVICE USED FOR BREAST HEALTH

STOCKTON, CALIFORNIA/March 6, /Date, 20132 / Newswire/ — Viratech, Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for a license issued to Viratech from Health Care Intellectual Properties, LLC.

The patent is called a “Method of Making and Using a Device to Warm the Breast Prior to, and to Assist with, the Elicitation of Fluid, As Part of a Nipple Aspirate Fluid Test Kit or Part of a Breast Ductal Therapy Infusion Kit or Breast Topical Therapy Protocol,” provisional patent application number 61518691.

Each year approximately 200,000 new patients with breast cancer are diagnosed in North America, and 50,000 of those will die of the disease. Despite billions of dollars poured into research, public awareness, and improved treatment, the statistics have shown only modest improvement over the past twenty years. The slight increase in survival is attributable somewhat to earlier diagnosis but mostly to improved treatment.

Post to Twitter

Galapagos receives EUR2.5 million IWT grant for IBD research

Category : Stocks, World News

MECHELEN, BELGIUM–(Marketwire – Jan 30, 2013) – Galapagos NV (Euronext: GLPG) announced
today that it has been awarded a EUR2.5 million grant from the Flemish
agency for
Innovation by Science and Technology (IWT) for inflammatory bowel disease
(IBD)
research and development. The goal of this 2.5-year project is to
identify new
therapeutic compounds for future treatment of IBD patients.

View original post here: Galapagos receives EUR2.5 million IWT grant for IBD research

Post to Twitter

Essex Reports Characteristics of 2012 Dividend

Category : Stocks

PALO ALTO, CA–(Marketwire – Jan 18, 2013) – Essex Property Trust, Inc., (NYSE: ESS) announced today the income tax treatment for its 2012 distributions to shareholders. The 2012 distribution characteristics are as follows:

More: Essex Reports Characteristics of 2012 Dividend

Post to Twitter

More NHS patients being treated by private firms, survey finds

Category : Business

Labour policy allowing private health firms to be paid from state funds has resulted in their share of NHS patients grow rapidly

Private firms now treat almost one in five NHS patients with certain conditions due to the last Labour government’s embrace of competition, an authoritative study reveals.

Allowing profit-driven health firms to be paid out of NHS funds has seen private operators grow from doing very few state-funded procedures to now being a “significant” provider of care, the Institute for Fiscal Studies (IFS) said in a report.

Private firms have made such inroads that independent sector treatment centres – facilities set up to treat NHS patients – now carry out 17% of hip replacements (11,500 operations), 17% of hernia repairs (9,000) and 6% of gall bladder removals (3,000) annually in England. Their share of NHS patients grew rapidly between 2006-07 and 2010-11 after Labour’s promotion of patient choice.

By 2010-11 private providers also handled 8% of patients’ first attendances in relation to orthopaedics or trauma, such as a broken limb; 4.8% of such attendances for gastroenterological problems; and 2.3% of attendances for sight problems.

In 2006, GPs typically referred patients to an average of 12 different healthcare providers a year, mainly in the NHS. By 2010 that had risen to 18, mainly because they were encouraged to offer patients a wider list of places to be treated.

The disclosure of how dramatically private firms expanded their role in the NHS during Labour’s time in power may prove politically difficult for the party, which regularly attacks the coalition for seeking to increase competition.

Labour said using independent centres had been necessary to clear a backlog of patients waiting for treatment and was unlike the coalition’s greater use of the private sector, which it accused of weakening the NHS by opening its “core” to competition. “Under Labour these agreements supplemented the mainstream NHS – giving it the extra capacity it needed to deliver the lowest ever waiting lists. This is very different to the current government’s privatisation of the core of the NHS,” said Jamie Reed, a shadow health minister and MP for Copeland.

“‘Any qualified provider’ [which lets private firms bid to run community health services] puts the private sector on the same footing as the NHS when competing for contracts. If the NHS loses out then its capacity to provide that service will shrink. The NHS must always be given the first opportunity to provide its own services,” Reed added.

A party spokesman added: “The last Labour government used these agreements to add extra capacity to the NHS and allow patients to be treated in record times. This Government’s eagerness to hand contracts to the private sector, in place of the NHS, whittles away the health service’s own capacity – that’s why the next Labour government will repeal this dangerous free-market free-for-all”.

The NHS Partners Network, an alliance of private providers of NHS care which is part of the NHS Confederation, said the findings showed GPs have been directing patients to non-NHS treatment services because they are better.”This is further evidence that patients do indeed want to have choice and will take advantage of it where it is in their interests to do so.

“It is also significant that the exercise of choice is now increasingly being supported by GPs where they consider it to be right for their patients. That means most GPs are, as one would expect, putting patients before politics,” said David Worskett, its director.

There are now 195 independent hospitals and treatment centres in England where patients can be treated at NHS prices under the “choose and book” system, which has significantly expanded choice, Worskett added. “While the overall proportion of NHS care delivered by the independent sector remains very low, at less than 5%, independent providers are very pleased to be making what is clearly a valued contribution to the NHS and patients in these challenging times.

“Quite obviously, as this study shows, the vast majority of patients continue to use their nearest NHS hospital, but where an alternative is more convenient or appropriate, patients clearly welcome this,” he said.

The latest official data from the NHS’s Health and Social Care Information Centre shows that the trend of growing numbers of NHS-funded procedures being carried out by private firms has continued under the coalition. They gave 345,200 NHS patients non-urgent treatments such as knee replacements and cataract removals in 2011-12, up almost 33,000 in a year, though that represented just 4.3% of all the 8m such procedures carried out that year, up from 4% a year earlier.

The British Medical Association said increasing competition could ultimately threaten the viability of NHS services. “The BMA has had concerns for a number of years about the ethos of promoting competition between different providers within the NHS as this could lead to a fragmentation and possible destabilisation of patient services,” said a spokesman.

Lord Howe, the health minister, said the quality of patient care and the fact it was free, not who provided it, was what mattered most. “The crucial thing here is that patients have access to the best possible services on the NHS and that they do so according to the founding principles of the health service – free at the point of delivery and available to all on the basis of need,” Howe said.

He defended the coalition’s expansion of private provision in the NHS, which has raised concern about wholesale privatisation. “We want to give patients more choice about where, when and how they can access their health services and patients are clearly making choices about services that meet a broad range of their needs.”

EpiCept Corp. (EPCT: OTC Link) | IMMUNE PHARMACEUTICALS AND EPICEPT CORPORATION AGREE TO MERGE

Category : Stocks, World News

< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

Post to Twitter